Novo Nordisk, FDA and Wegovy

As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (LLY 0.74%) and Novo Nordisk (NVO -0.28%), there's now one more big reason to ex ...
A former regional account manager working for Novo Nordisk Inc. is suing the healthcare company, alleging it failed to ...
Novo Nordisk (NVO) has released an update. Novo Nordisk has been actively engaged in a share repurchase program, aiming to buy back B shares ...
Novo Nordisk faces competition from Eli Lilly in new therapeutic areas. Read why I rate NONOF stock as a hold.
Roche recently joined naysayers who argue the deal threatens competition in the burgeoning weight loss and diabetes drug ...
The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of ...
Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...